• Home

  • About Hiray

    • Corporate Culture

    • Team Style

    • Remember H

    • Company News

  • API Intermediates Service

    • API and intermediates process development services

      • Process design, development and optimization

      • API Total Quality Research

      • Process validation

      • Product lifecycle management

      • API Technology Platform

    • API and intermediates manufacturing services

      • Non GMP/GMP pilot and commercial production

    • Registration Filing and Regulatory Services

      • Extensive team experience

      • Regulatory Support

      • Register for the service

      • Declaration document writing services

      • On-site verification

    • Service & Support

      • Customer-centric project management

      • CMC registration support

  • Products

    • Orforglipron series

    • API

    • Intermediate KSM

  • Compliance

    • SHE management system

    • Quality Management System

    • IP protection

  • Contact US

    • Visit Registration

    • Contact information

    • Foreign Business Consulting

    • Domestic business consulting

    • Join Hiray

  • 中文

027-87399570

Orforglipron series

关键词:

产品 新闻 下载

最新产品

Orforglipron intermediate 2212021-82-2

Orforglipron intermediate 3047556-95-3

Orforglipron intermediate 2212022-55-2

Orforglipron intermediate 2212022-56-3

Orforglipron intermediate 2212022-57-4

ORFORGLIPRON N-7 3047293-01-3

ORFORGLIPRON N-83047292-99-6

Orforglipron intermediate2212021-79-7

1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-teChemicalbooktrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(3008544-96-2

Ogleron intermediate 1784678-61-0

最新新闻

【Event Review】Hiray Pharmaceutical's CPHI China 2026 Shanghai Journey Comes to a Perfect Close

Hiray Pharma Solutions Ltd. is pleased to announce our participation in CPHI & PMEC China 2026 in Shanghai.

Research on Process Control of Indole Fragment Diastereomeric Impurities in Orforglipron

Congratulations on a Landmark Publication in Nature Communications

Hiray Pharma Pushes GLP-1 Chemistry Forward

Synthesis of (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride, an intermediate of Orforglipron

Hiray Pharma Solutions Ltd.

Address: No.1 Xinghua 3rd Road, Duodao District, Jingmen City, Hubei Province
Operator: +86-724-6805666
Post code: 448000

Domestic business

Tel:+86 13618667608
Email: maggie_q@hiraypharma.com

International business

Tel:+1 (919) 998-9321
Email: info@hiraypharma.us

HR Recruit

Email: info@hiraypharma.com
Responsible for receiving resumes submitted by candidates

Hiray WeChat

Hiray WeChat

Hiray Video

Hiray Video

Copyright Hiray Pharma Solutions Ltd. | Business License

Powered by:CEglobal  | SEO

Consultation Hotline:

Twitter:

Facebook:

linkedin:

Instagram:

YouTube:

E-mail:

E-mail: